Inogen | INGN - Equity Capital And Reserves


Inogen reported $197.18M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Accuray USD 61.87M 19.3M Sep/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 448.23M 9.54M Dec/2025
AtriCure USD 491.94M 15.43M Dec/2025
Baxter International USD 6.04B 86M Mar/2026
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Boston Scientific USD 25.86B 1.63B Mar/2026
Chart Industries USD 3.23B 28.2M Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
Dexcom USD 2.96B 210.9M Mar/2026
Edwards Lifesciences USD 10.34B 132.6M Dec/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.52B 131.1M Dec/2025
Masimo USD 721.2M 88.8M Dec/2025
Medtronic USD 48.99B 128M Dec/2025
Orthofix International USD 435.19M 14.85M Mar/2026
Philips EUR 10.58B 204M Sep/2025
ResMed USD 6.49B 171.03M Mar/2026
Steris USD 7.15B 145.4M Dec/2025
Stryker USD 22.42B 635M Dec/2025
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
X T L Biopharmaceuticals USD -47K 5.48M Jun/2025
Zimmer Biomet Holdings USD 12.68B 16.1M Mar/2026